Freenome (FRNM)
Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detectio...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Freenome Analyst Rating
View moreForecast & Rating
Aug 20, 2026Price forecast
$18.0014.65%
Forecast & RatingStrong buy
5analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- rttnews · 2 days ago, 01:38 PM
Biotech Stocks At 52-Week Highs - HSCS +7%, FRNM +5%, VOGX, HTFL, HALO
- Market Beat · Aug 27 at 08:00 PM
Freenome (NASDAQ:FRNM) Sees Large Growth in Short Interest
- PUBT · Aug 12 at 03:15 PM
FDA grants Breakthrough Device designation to Freenome SimpleScreen Lung test
- TradingView · Jul 27 at 12:13 PM
Freenome's SimpleScreen CRC gains FDA approval; $100M Abbott milestone, Medicare coverage expected
